Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Kripthonite Therapeutics ApS
APS
Active
CVR 43770209
Palle Juul-Jensens Boulevard 82, 8200
Aarhus N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 3 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Kripthonite Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
-4M
2025
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
0M
2023
0M
0%
2024
-5M
-500%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
542
125
-3.513
Staff expenses
-546
-125
-1.431
EBITDA
-5
0
-4.944
Depreciation & amort.
-0
-0
-0
EBIT
-5
0
-4.944
Net financials
-1
-0
-24
Profit before tax
-5
-0
-4.967
Tax
-0
-0
-1.031
Net profit
-5
-0
-3.936
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
75
169
4.793
Equity
35
35
4.598
Long-term debt
0
0
0
Short-term debt
41
134
195
Total debt
41
134
195
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-494359000.0%
This company
2023
2025
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
2023
2025
Return on equity
-85.6%
This company
18.4%
Market median
-565% vs market
2023
2025
Net profit margin (of gross profit)
-393627400.0%
This company
2023
2025
Asset turnover (of gross profit)
-0.73×
This company
2023
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-10 – 2023-12-31
View
PDF
More on Kripthonite Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
